Rubicon Research Acquires Impopharma Canada

Thane, Mumbai (India), 7th Jan 2020

As part of its ongoing effort to establish a global development network, Rubicon Research Private Limited, a leading specialty pharmaceutical company, today announced the acquisition of Impopharma Canada Limited with operations in Ontario, Canada.

Rubicon Research Announces Commencement of Analytical Services

Thane, Mumbai (India), 2nd Sept 2019

Rubicon announces offering of analytical services as standalone activity from its cGMP plant location. We base our approach on our expertise in Analytical Method Development and GMP Quality Control Testing. This service supplements our stability storage and stability samples analysis service from well controlled stability study infrastructure.

Rubicon Research and General Atlantic Announce Strategic Partnership

Thane, Mumbai (India), 8th Apr 2019

Rubicon Research Pvt Ltd (“Rubicon”), a global leader in innovative pharmaceutical product development, announced today that General Atlantic has become a significant shareholder in the company. General Atlantic, a leading global growth equity firm, is committing up to $100 million of primary capital and has acquired the stake held by Rubicon’s existing private equity shareholders. All other existing shareholders continue to maintain their shareholding in the company.